Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir, and Lamivudine Tablets in Children with HIV (IMPAACT 2019): Week 24 Results of an Open-Label, Multicentre, Phase 1-2 Dose-Confirmation Study.Kristina M. Brooks,Jennifer J. Kiser,Lauren Ziemba,Shawn Ward,Yasha Rani,Tim R. Cressey,Gaerolwe R. Masheto,Haseena Cassim,Jaime G. Deville,Ponego L. Ponatshego,Faeezah Patel,Linda Aurpibul,Shaun L. Barnabas,Iris Mustich,Anne Coletti,Barbara Heckman,Chelsea Krotje, Mark Lojacono,Dwight E. Yin,Ellen Townley,Jack Moye,Sai Majji,Edward P. Acosta,Kevin Ryan,Hardik Chandasana,Cynthia H. Brothers,Ann M. Buchanan,Helena RabieThe lancet HIV（2023）引用 1|浏览56暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
